These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23475493)

  • 1. [Bacteria and viruses modulate FcεRI-dependent mast cell activity].
    Słodka A; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():164-73. PubMed ID: 23475493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.
    Suurmond J; Dorjée AL; Knol EF; Huizinga TW; Toes RE
    Clin Exp Allergy; 2015 Apr; 45(4):788-96. PubMed ID: 25665021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoglobulin E-Toll-like receptor network.
    Novak N; Bieber T; Peng WM
    Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell cytokine and chemokine responses to bacterial and viral infection.
    Marshall JS; King CA; McCurdy JD
    Curr Pharm Des; 2003; 9(1):11-24. PubMed ID: 12570671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role Played by Autophagy in FcεRI-Dependent Activation of Mast Cells.
    Pavlyuchenkova AN; Smirnov MS; Chernyak BV; Chelombitko MA
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Mechanistic Advances in FcεRI-Mast Cell-Mediated Allergic Signaling.
    Li Y; Leung PSC; Gershwin ME; Song J
    Clin Rev Allergy Immunol; 2022 Dec; 63(3):431-446. PubMed ID: 36251242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond.
    Dema B; Suzuki R; Rivera J
    Int Arch Allergy Immunol; 2014; 164(4):271-9. PubMed ID: 25227903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation.
    Uchida R; Egawa T; Fujita Y; Furuta K; Taguchi H; Tanaka S; Nishida K
    Mol Immunol; 2019 Jan; 105():32-37. PubMed ID: 30472514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
    MacNeil AJ; Yang YJ; Lin TJ
    J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2.
    Yoshioka M; Fukuishi N; Iriguchi S; Ohsaki K; Yamanobe H; Inukai A; Kurihara D; Imajo N; Yasui Y; Matsui N; Tsujita T; Ishii A; Seya T; Takahama M; Akagi M
    J Allergy Clin Immunol; 2007 Aug; 120(2):452-61. PubMed ID: 17481719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
    Samayawardhena LA; Pallen CJ
    J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the FcepsilonRI beta-chain in allergic diseases.
    Kraft S; Rana S; Jouvin MH; Kinet JP
    Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Picture of Mast Cell Activation: The Complex Regulatory Network of High-Affinity Receptor for Immunoglobulin E Signaling.
    Suzuki R
    Biol Pharm Bull; 2017; 40(11):1828-1832. PubMed ID: 29093329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation.
    Kambayashi T; Larosa DF; Silverman MA; Koretzky GA
    Immunol Rev; 2009 Nov; 232(1):99-114. PubMed ID: 19909359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mast cell activation through FcepsilonRI.
    Yamasaki S; Saito T
    Chem Immunol Allergy; 2005; 87():22-31. PubMed ID: 16107760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
    Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
    Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.